Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

M. Chesi, E. Nardini, L. A. Brents, E. Schrock, T. Ried, W. M. Kuehl, P. L. Bergsagel

Research output: Contribution to journalArticle

545 Scopus citations

Abstract

Dysregulation of oncogenes by translocation to the IgH locus (14q32) is a seminal event in the pathogenesis of B-cell tumours. In multiple myeloma (MM), translocations to the IgH locus have been reported at an incidence of 20-60%. For most translocations, the partner chromosome is unknown (14q+); for the others, a diverse array of chromosomal partners have been identified, with 11q13 (cyclin D1) the only chromosome that is frequently involved2-6. Recently, we developed a Southern-blot assay that detects translocation breakpoint fragments in most MM tumour, including those with no translocation detected by conventional karyotyping6. In a continuing analysis of translocations in 21 myeloma cell lines and primary tumours, we show that the novel, karyotypically silent translocation t(4;14)(p16.3;q32.3) is present in five lines and at least three of ten primary tumours. The chromosome-4 breakpoints are clustered in a 70-kb region centromeric to the fibroblast growth factor receptor 3 gene (FGFR3), the apparent dysregulated oncogene. Two lines and one primary tumour with this translocation selectively express an FGFR3 allele containing activating mutations identified previously in thanatophoric dwarfism. We propose that after the t(4;14) translocation, somatic mutation during tumour progression frequently generates an FGFR3 protein that is active in the absence of ligand.

Original languageEnglish (US)
Pages (from-to)260-264
Number of pages5
JournalNature Genetics
Volume16
Issue number3
DOIs
StatePublished - Jul 16 1997

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3'. Together they form a unique fingerprint.

  • Cite this